Merger activity decreased last week with three new deals announced and ten pending deals closing.
|Total Number of Deals Closed in 2019||116|
|Total Number of Deals Not Completed in 2019||8|
|Total Number of Pending Deals|
|Stock & Cash Deals||13|
|Total Number of Pending Deals||74|
|Total Deal Size||$1.11 trillion|
Top 10 deals with largest spreads:
|Symbol||Announced Date||Acquiring Company||Closing Price||Last Price||Closing Date||Profit||Annualized Profit|
|PACB||11/01/2018||Illumina, Inc. (ILMN)||$8.00||$5.43||12/31/2019||47.33%||116.73%|
|STC||03/19/2018||Fidelity National Financial, Inc. (FNF)||$52.56||$37.75||09/30/2019||39.24%||255.76%|
|GNW||10/23/2016||China Oceanwide Holdings Group Co., Ltd. (N/A)||$5.43||$3.94||11/30/2019||37.82%||117.98%|
|S||04/29/2018||T-Mobile US, Inc. (TMUS)||$7.97||$6.76||07/29/2019||17.93%||-934.86%|
|AVP||05/22/2019||Natura Cosméticos S.A. (OTC:NUACF)||$4.93||$4.34||01/31/2020||13.57%||27.67%|
|ONCE||02/25/2019||Roche Holding AG (OTCQX:RHHBY)||$114.50||$101.53||04/30/2020||12.77%||17.33%|
|MLNX||03/11/2019||Nvidia Corporation (NVDA)||$125.00||$111.38||12/31/2019||12.23%||30.16%|
|AGN||06/25/2019||AbbVie Inc. (ABBV)||$176.89||$161.02||03/31/2020||9.86%||15.05%|
|OHAI||08/01/2019||Portman Ridge Finance Corporation (PTMN)||$1.46||$1.33||12/31/2019||9.77%||24.11%|
|CRZO||07/15/2019||Callon Petroleum Company (CPE)||$9.37||$8.72||12/31/2019||7.44%||18.34%|
Disclaimer: I hold long positions in Mellanox Technologies, Pacific Biosciences of California, Celgene, Bristol-Myers Squibb, and Finisar (FNSR). Please do your own due diligence before buying or selling any securities mentioned in this article. We do not warrant the completeness or accuracy of the content or data provided in this article.
This article was written by
I am an entrepreneur and investor with a focus on event driven strategies including merger arbitrage, spinoffs, (legal) insider trading, buybacks and SPACs. I was one of the earliest contributors on Seeking Alpha and started publishing here in 2005. For more than a decade I have been writing every week about M&A and interesting insider transactions. My work has been mentioned in Barron's, Dow Jones, BNN Bloomberg and other publications.
I have been an active investor for more than two decades and my background in technology has helped me built tools that inform my investing process, especially as it relates to event-driven strategies that require updated data and processes. The focus on my Inside Arbitrage service is to provide investors with the right combination of tools and analysis to help them take advantage of strategies that can perform well across market cycles.
Disclosure: I am/we are long MLNX, PACB, CELG, BMY, FNSR. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.